Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix Inc
(NQ:
BDSX
)
1.790
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biodesix Inc
< Previous
1
2
3
4
Next >
Biodesix Announces Second Quarter 2024 Results and Highlights
August 07, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
August 06, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
June 18, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Investor Conferences in June
May 28, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
May 21, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
May 08, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
May 07, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
April 09, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
April 05, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
March 25, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
March 01, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
February 26, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
February 16, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
November 14, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in November
November 09, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Third Quarter 2023 Results and Highlights
November 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
October 03, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
September 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in September
September 05, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
August 22, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2023 Results and Highlights
August 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
July 12, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services
July 06, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
June 27, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
June 01, 2023
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.